Cargando…

Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma

Esophageal carcinoma is among the most common cancers worldwide and a leading cause of cancer death [1]. Large numbers of studies indicated that chronic inflammation is closely associated with its development [21, 25]. Furthermore, the JAK/STAT pathway, which plays a critical role in inflammation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Fang, Yang, Xiawen, Liu, Ying, Yuan, Xiao, Fan, Tianli, Zhang, Fanmiao, Zhao, Jimin, Lu, Jing, Jiang, Yanan, Dong, Ziming, Yang, Yili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687640/ https://www.ncbi.nlm.nih.gov/pubmed/29179470 http://dx.doi.org/10.18632/oncotarget.20838

Ejemplares similares

The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma
por: Liu, Ying, et al.
Publicado: (2018)

Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
por: Yang, Yi, et al.
Publicado: (2017)

TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019)

Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2020)

STAT1 inhibits STAT3 activation in esophageal squamous cell carcinoma
por: Liu, Zhaoyong, et al.
Publicado: (2018)

Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation
por: Li, Bo, et al.
Publicado: (2021)

The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma
por: Zhang, Ying, et al.
Publicado: (2014)

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023)

Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
por: Zhu, Lili, et al.
Publicado: (2020)

ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma
por: Wang, Hu, et al.
Publicado: (2017)

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
por: Li, Zhenzhen, et al.
Publicado: (2020)

STAT1β enhances STAT1 function by protecting STAT1α from degradation in esophageal squamous cell carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)

Correlation of STAT1 with Apoptosis and Cell-Cycle Markers in Esophageal Squamous Cell Carcinoma
por: Zhang, Ying, et al.
Publicado: (2014)

Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2021)

Development of a Novel Highly Spontaneous Metastatic Model of Esophageal Squamous Cell Carcinoma Using Renal Capsule Technology
por: Gao, Pan, et al.
Publicado: (2021)

STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma
por: Zheng, Zhen-Yuan, et al.
Publicado: (2021)

JAK/STAT3 signaling pathway mediates endothelial-like differentiation of immature dendritic cells
por: JIN, GUOGUO, et al.
Publicado: (2015)

Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data
por: Zhang, Lemeng, et al.
Publicado: (2020)

Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma
por: Zheng, Zhen-Yuan, et al.
Publicado: (2022)

Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation
por: Zhao, Simin, et al.
Publicado: (2019)

Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021)

Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells
por: Liu, Haidan, et al.
Publicado: (2014)

Small Extracellular Vesicles in the Development, Diagnosis, and Possible Therapeutic Application of Esophageal Squamous Cell Carcinoma
por: Zhao, Zheng, et al.
Publicado: (2021)

Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway
por: Luo, Hongtao, et al.
Publicado: (2020)

RNF6 activates TGF-β1/c-Myb pathway to promote EMT in esophageal squamous cell carcinoma
por: Cheng, Jingge, et al.
Publicado: (2023)

LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway
por: Luo, Hongtao, et al.
Publicado: (2023)

Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
por: Feng, Y, et al.
Publicado: (2014)

Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
por: Xie, Yifei, et al.
Publicado: (2020)

ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2022)

Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma
por: Li, Min, et al.
Publicado: (2013)

p21‐activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1
por: Huang, Hui, et al.
Publicado: (2020)

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021)

Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
por: Liu, Xinning, et al.
Publicado: (2023)

Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis
por: Hsiao, J-R, et al.
Publicado: (2003)

Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation
por: Ji, Yubin, et al.
Publicado: (2019)

IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway
por: Ma, Zhiyu, et al.
Publicado: (2021)

Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma
por: Yuan, Qiang, et al.
Publicado: (2019)

Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy
por: Yang, Wanli, et al.
Publicado: (2019)

The Establishment of Esophageal Precancerous Lesion Model by Using p53 Conditional Knockout Mouse in Esophageal Epithelium
por: Zhu, Lili, et al.
Publicado: (2020)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8quck2cpr9ltf6jd34u2jbf4ru